22,23-Dihydroavermectin B1a aglycon
Product Specifications
UNSPSC Description
22,23-Dihydroavermectin B1a aglycon is an acid degradation product produced by hydrolysis of the disaccharide unit of ivermectin. It can inhibit nematode larval development, but does not cause paralytic activity.
Target Antigen
Parasite
Type
Reference compound
Related Pathways
Anti-infection
Field of Research
Infection
Assay Protocol
https://www.medchemexpress.com/22-23-dihydroavermectin-b1a-aglycon.html
Smiles
C[C@H]([C@@]1([H])O[C@]2(CC[C@@H]1C)C[C@](OC([C@@](C=C3C)([H])[C@]4([C@]([C@@H]3O)([H])OC/C4=C\C=C\[C@@H]5C)O)=O)([H])C[C@](C/C=C([C@H]5O)\C)([H])O2)CC
Molecular Weight
586.76
References & Citations
[1]Chabala, et al. Ivermectin, a new broad-spectrum antiparasitic agent. J. Med. Chem. 23(10), 1134-1136 (1980).
Shipping Conditions
Room temperature
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-137252/22-23-Dihydroavermectin-B1a-aglycon-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-137252/
Clinical Information
No Development Reported
CAS Number
73162-95-5
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
![Elab Fluor® 488 Anti-Mouse CD24 Antibody[M1/69]](https://cdn.genprice.uk/genprice/genprice5.png)
